Skip to content
Adjuvance Technologies

Adjuvance Technologies

Empowering health.

  • About Us
  • Our Technology
  • Our Leadership
    • Board of Directors
    • Management Team
  • Investors & Media
  • Contact

Adjuvance Technologies Press Releases

Category: Press Release

ADJUVANCE TECHNOLOGIES ANNOUNCES NIH FUNDING FOR COVID-19 VACCINE RESEARCH

May 19, 2020Press Release

[LINCOLN, NE, 19 MAY 2020]   Adjuvance Technologies announced today that it has been awarded supplemental contract funding from The National Institute of Allergy and Infectious Diseases (NIAID).  The funds will be used to evaluate TQL1055, manufactured by Adjuvance, with SARS-CoV2 […]

Read More

Posts navigation

Older posts

Recent Posts

  • ADJUVANCE PRESENTS ITS 2021 POTENTIAL AND PLANS AT THE BIOTECH SHOWCASE
  • ADJUVANCE TECHNOLOGIES ANNOUNCES NIH FUNDING FOR COVID-19 VACCINE RESEARCH
  • ADJUVANCE TECHNOLOGIES ANNOUNCES $20 MILLION SERIES A INVESTMENT FROM MORNINGSIDE VENTURE INVESTMENTS
  • Comparative preclinical evaluation of AS01 versus other Adjuvant systems in a candidate herpes zoster glycoprotein E subunit vaccine
  • NEJM Reports Efficacy of QS-21 Containing Herpes Zoster Subunit Vaccine
Copyright © All rights reserved. Theme Businessbiz by Sensational Theme